Clinical Trial Update: Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma

View source ↗

Summary

This clinical trial update describes a neoadjuvant chemo-immunotherapy approach and investigation of tumor microenvironment changes in esophageal squamous cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Nanjing Medical University | Conditions: Esophageal Squamous Cell Carcinoma | Status: NOT_YET_RECRUITING